We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
(-12%)
Cap. Flow
-$392M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$100M |
| 2 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$97M |
| 3 |
Lam Research
LRCX
|
+$85.4M |
| 4 |
Boston Scientific
BSX
|
+$79.4M |
| 5 |
Merck
MRK
|
+$67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$145M |
| 2 |
ASML
ASML
|
+$119M |
| 3 |
Qorvo
QRVO
|
+$89M |
| 4 |
Microsoft
MSFT
|
+$82.9M |
| 5 |
Intuitive Surgical
ISRG
|
+$75.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.56% |
| 2 | Technology | 29.01% |
| 3 | Industrials | 8.79% |
| 4 | Communication Services | 5.99% |
| 5 | Financials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Monster Beverage
MNST
$92.5B
| $22.9M | 0.37% |
572,188
+241,504
| +73% | +$10.1M |
|
77
Cisco
CSCO
$479B
| $22.8M | 0.37% |
+409,111
| New | +$23.1M |
|
|
GTM
78
ZoomInfo Technologies
GTM
$1.11B
| $22.8M | 0.37% |
+381,161
| New | +$20.5M |
|
79
Rogers Corp
ROG
$2.37B
| $22.8M | 0.37% |
83,760
+28,956
| +53% | +$7.9M |
|
|
SAFM
80
DELISTED
Sanderson Farms Inc
SAFM
| $22.7M | 0.37% |
120,959
+29,616
| +32% | +$5.42M |
|
|
CCMP
81
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $22.4M | 0.36% |
120,989
+66,095
| +120% | +$12.2M |
|
82
Pentair
PNR
$10.9B
| $22.1M | 0.36% |
408,032
+223,315
| +121% | +$13.5M |
|
83
Guidewire Software
GWRE
$13.3B
| $21.8M | 0.35% |
+230,773
| New | +$22.1M |
|
84
Mercado Libre
MELI
$97.7B
| $21.7M | 0.35% |
+18,283
| New | +$19.9M |
|
85
Parker-Hannifin
PH
$126B
| $21.1M | 0.34% |
74,357
-47,153
| -39% | -$14.2M |
|
|
TGNA
86
DELISTED
TEGNA Inc
TGNA
| $20.8M | 0.34% |
+930,000
| New | +$19.5M |
|
87
Tower Semiconductor
TSEM
$24.8B
| $20.7M | 0.34% |
+427,640
| New | +$18M |
|
88
AnaptysBio
ANAB
$1.63B
| $20.6M | 0.33% |
833,927
+223,946
| +37% | +$6.78M |
|
89
Nokia
NOK
$54.2B
| $20.3M | 0.33% |
3,716,806
+1,583,596
| +74% | +$8.77M |
|
|
NVRO
90
DELISTED
NEVRO CORP.
NVRO
| $20M | 0.33% |
276,881
+177,876
| +180% | +$12.8M |
|
91
Senti Biosciences Holdings
SNTI
$12.1M
| $19.7M | 0.32% |
200,000
| – | – |
|
92
Celldex Therapeutics
CLDX
$3.09B
| $19.7M | 0.32% |
579,192
+319,297
| +123% | +$10.2M |
|
|
IPG
93
DELISTED
Interpublic Group of Companies
IPG
| $19.7M | 0.32% |
+555,030
| New | +$20M |
|
94
Netflix
NFLX
$308B
| $19.6M | 0.32% |
+524,480
| New | +$21.8M |
|
95
Calidi Biotherapeutics
CLDI
$2.05M
| $19.6M | 0.32% |
1,031
| – | – |
|
96
Vertex Pharmaceuticals
VRTX
$122B
| $19.5M | 0.32% |
74,671
-29,109
| -28% | -$6.91M |
|
|
PLAN
97
DELISTED
Anaplan, Inc.
PLAN
| $19.4M | 0.31% |
297,600
+7,776
| +3% | +$379K |
|
98
Fox Class A
FOXA
$24.4B
| $19.3M | 0.31% |
489,651
-249,392
| -34% | -$10.1M |
|
99
RingCentral
RNG
$5.12B
| $19.2M | 0.31% |
+163,784
| New | +$24.1M |
|
|
ACDI
100
DELISTED
Ascendant Digital Acquisition Corp. III
ACDI
| $19.1M | 0.31% |
+1,912,500
| New | +$19M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.
- Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
- Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
- Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
- Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
- Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
- Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
- Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.
Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.